Envestnet Asset Management Inc. increased its stake in SunOpta Inc. (NASDAQ:STKL - Free Report) TSE: SOY by 17.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,092,334 shares of the company's stock after purchasing an additional 160,879 shares during the quarter. Envestnet Asset Management Inc. owned about 0.91% of SunOpta worth $8,411,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of STKL. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in SunOpta during the fourth quarter valued at about $733,000. Barclays PLC increased its holdings in shares of SunOpta by 103.3% in the 3rd quarter. Barclays PLC now owns 178,954 shares of the company's stock valued at $1,142,000 after purchasing an additional 90,937 shares during the period. State Street Corp increased its holdings in shares of SunOpta by 18.9% in the 3rd quarter. State Street Corp now owns 1,827,273 shares of the company's stock valued at $11,658,000 after purchasing an additional 290,372 shares during the period. Geode Capital Management LLC increased its holdings in SunOpta by 80.9% in the third quarter. Geode Capital Management LLC now owns 2,127,890 shares of the company's stock worth $13,579,000 after buying an additional 951,462 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in SunOpta by 12.3% in the third quarter. JPMorgan Chase & Co. now owns 515,170 shares of the company's stock worth $3,287,000 after buying an additional 56,621 shares during the last quarter. Institutional investors and hedge funds own 85.39% of the company's stock.
Analysts Set New Price Targets
A number of research firms recently commented on STKL. Stephens restated an "overweight" rating and issued a $10.00 price objective on shares of SunOpta in a report on Thursday, January 2nd. StockNews.com raised shares of SunOpta from a "sell" rating to a "hold" rating in a research report on Tuesday, March 11th.
Get Our Latest Report on STKL
SunOpta Stock Up 1.8 %
Shares of STKL stock traded up $0.07 on Thursday, hitting $4.11. 47,621 shares of the stock were exchanged, compared to its average volume of 757,033. The company has a current ratio of 1.20, a quick ratio of 0.53 and a debt-to-equity ratio of 1.61. The firm has a market capitalization of $492.43 million, a P/E ratio of -22.75 and a beta of 1.83. The business has a 50-day moving average of $5.24 and a 200 day moving average of $6.55. SunOpta Inc. has a fifty-two week low of $3.65 and a fifty-two week high of $8.11.
SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last released its earnings results on Wednesday, February 26th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.06. SunOpta had a positive return on equity of 7.92% and a negative net margin of 2.74%. The business had revenue of $193.91 million for the quarter, compared to analyst estimates of $189.90 million. Equities analysts anticipate that SunOpta Inc. will post 0.13 EPS for the current year.
Insider Buying and Selling at SunOpta
In other SunOpta news, SVP Bryan P. Clark sold 8,500 shares of the company's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $5.32, for a total value of $45,220.00. Following the sale, the senior vice president now owns 28,150 shares in the company, valued at $149,758. This represents a 23.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 6.48% of the company's stock.
SunOpta Company Profile
(
Free Report)
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Further Reading

Before you consider SunOpta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.
While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.